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Abstract
Background: Athletic performance without beneﬁt from performance-enhancing substances is
essential in amateur sports; yet, prohibiting speciﬁc medications creates discrimination against
competitors with a medical illness. To avoid such inequalities, the World Anti-Doping Agency
(WADA) adopted international standards for therapeutic use exemptions (TUE). Attention-
deﬁcit/hyperactivity disorder (ADHD) treatment within the athletic population is a unique
challenge. Stimulants, ﬁrst-line treatment for ADHD, are prohibited unless alternative, non-
prohibited medications have ﬁrst been tried and found ineffective. The world prevalence of
ADHD is 5.3%; however, there are no ADHD prevalence studies in sports. This paper addresses
ADHD in a boys’ gymnastics team, implications for further research with a proposed survey-
questionnaire to measure prevalence of ADHD with behavioral effects of gymnastics, and ethical
considerations.
Method: Preliminary ADHD prevalence in a boys’ gymnastics team is presented with complemen-
tary literature review and a proposed survey-questionnaire to estimate actual ADHD prevalence
in gymnastics populations with behavioral effects.
Results: The parents of boys in a gymnastic reported that 5 of 7 (71.4%) boys were either diag-
nosed with ADHD in the past or had been treated with stimulant or non-stimulant medications
for inattentive/hyperactive/impulsive behaviours. Parents described gymnastics as effective
′′behavioral therapy′′ in controlling/improving ADHD symptoms, with this effect extending into
other environments (home/classroom). Only one parent was aware of WADA stimulant prohibi-
tion.
Conclusions: A surprisingly large ADHD prevalence is reported in one boys’ gymnastic team.
Further research is required to verify this high ADHD prevalence and behavioral effects in
cargado de http://www.apunts.org el 29/06/2011. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato.gymnastics. A proposed survey-questionnaire to measure both ADHD prevalence and behavioral
effects in gymnastics is presented.
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Trastorno de déﬁcit de atención/hiperactividad (TDAH) en gimnasia: resultados
preliminares
Resumen:
Antecedentes: En el deporte amateur es esencial alcanzar un rendimiento deportivo sin el
beneﬁcio de sustancias que lo mejoren. Sin embargo, la prohibición de determinados fármacos
genera una discriminación a los competidores con determinadas enfermedades. Para evitar esas
desigualdades, la Agencia Mundial Antidopaje (AMA) aprobó las normas internacionales para la
autorización de uso terapéutico (AUT). El tratamiento del trastorno de déﬁcit de atención e
hiperactividad (TDAH) supone un desafío único en el deporte. Los estimulantes, el tratamiento
de primera línea para el TDAH, están prohibidos a menos que haya medicamentos alternativos
que hayan sido previamente evaluados y declarados ineﬁcaces. La prevalencia mundial del
TDAH es del 5,3%; sin embargo, no existen estudios de afectación de esta enfermedad en los
deportistas. Este artículo aborda el TDAH en un equipo masculino de gimnasia, las consecuencias
para investigaciones futuras utilizando una propuesta de encuesta-cuestionario para medir la
prevalencia de este trastorno y sus efectos sobre el comportamiento en los gimnastas y sus
consideraciones éticas.
Método: La prevalencia del TDAH preliminar en el equipo de chicos de gimnasia se presenta con
la revisión de la bibliografía complementaria y una propuesta de encuesta-cuestionario para
estimar la afectación real de TDAH entre los gimnastas con trastornos de comportamiento.
Resultados: En un equipo de gimnasia masculino, los padres informaron que 5 de 7 chicos (71,4%)
en el pasado habían recibido un diagnóstico de TDAH o habían sido tratados con medicamen-
tos, estimulantes o no estimulantes, por falta de atención y comportamientos hiperactivos e
impulsivos. Los padres describieron la gimnasia como una eﬁcaz ′′terapia del comportamiento′′
en el control y mejora de los síntomas del TDAH; este efecto también se obtuvo en otros
ámbitos (hogar/aula). Sólo uno de los padres era consciente de la prohibición del consumo de
estimulantes por parte de la AMA.
Conclusiones: Se detectó una prevalencia sorprendentemente alta de TDAH en el un equipo de
gimnasia masculino. Se requiere más investigación para veriﬁcar esta alta prevalencia del TDAH
y los efectos sobre el comportamiento de los gimnastas. Se presenta una propuesta de encuesta-
cuestionario para medir la prevalencia de trastorno de déﬁcit de atención e hiperactividad en
la gimnasia.
© 2010 Consell Català de l’Esport. Generalitat de Catalunya. Publicado por Elsevier España,
S.L. Todos los derechos reservados.
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he concept that all athletes compete on ′′an even play-
ng ﬁeld′′ without the beneﬁt of performance-enhancing
ubstances is essential to the existence of amateur
ports. Unfortunately, too often, performance-enhancing
ubstances have tainted international competitions. For that
eason, the World Anti-Doping Agency (WADA) with asso-
iated World Anti-Doping Code (WADC) was created with
ar-ranging sanctions inclusive of simple warnings, com-
etition disqualiﬁcations, and lifetime suspensions1,2. A
ubstance or method will be included on the Prohibited
ist if WADA determines that two of three major criteria
re met: 1) substance or method results in actual/potential
erformance enhancement, 2) substance or method is actu-
lly/potentially dangerous to the athlete, and 3) substance
r method violates the spirit of sport (WADC 4.3.1); further,
substance or method will be included on the Prohibited list
f it could serve to mask the use of another prohibited sub-
tance or method (WADC 4.3.2)2. Fundamental to the WADC
s the concept of strict liability (WADC 2.1.1 and Comment
.1.1)2. The athlete takes personal responsibility for any
nd all substances that might enter his body whether or not
e knowingly ingested such. If the athlete tested positive
a
o
h
cor a prohibited substance, whether the athlete took such
ntentionally or not, and even if that substance would not
ave enhanced the athlete’s performance, so long as that
ubstance is listed as prohibited, the athlete committed a
oping offense and must suffer the consequences2,3. This is a
ritical issue for Olympic athletes have been disqualiﬁed and
ost their medals secondary to receiving relatively innocuous
old preparations from coaches or trainers. The most telling
ase, which is pertinent to the ﬁndings in this article, con-
erns a 16-year-old Romanian gymnast who was stripped of
he Sydney 2000 Olympic Games women’s all-around gold
edal when she tested positive for pseudoephedrine after
aking OTC cold tablets3—5. Though she was unaware of the
resence of a prohibited substance (given by her team doc-
or), and though it made her dizzy and further though expert
pinion felt that she had not gained competitive advantage
i.e., the prohibited substance did not enhance her perfor-
ance), the Court of Arbitration for Sport (CAS) conﬁrmed
hat the gymnast had committed a doping offense3—5. The
AS held and commented: ‘The IOC’s decision was upheld
nd the application dismissed. Doping is a strict liability
ffence. The mere presence in the urine sample of a pro-
ibited substance or a relevant substance at a prohibited
oncentration is sufﬁcient to establish the offence. It is
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not necessary in establishing the offence to demonstrate
that the athlete secured a competitive advantage. The
subjective elements argued in the attack on the ﬁnding of
doping were only relevant to the assessment of any disci-
plinary sanction5.′′
′′The system of strict liability of the athlete must prevail
when sporting fairness is at stake. This means that, once a
banned substance is discovered in the urine or blood of an
athlete, he must automatically be disqualiﬁed from the com-
petition in question, without any possibility for him to rebut
this presumption of guilt. So the CAS ﬁrmly upheld. The Anti-
Doping Code had to be enforced ‘without compromise.’ That
the applicant had taken Nurofen for a cold, not to gain a
competitive advantage was irrelevant. As was expert opinion
that she had obtained no such advanatage5.′′
Prohibition of speciﬁc medications might create novel
discrimination against medically ill competitors6—9. In order
to avoid such inequities, an international standard for ther-
apeutic use exemptions (TUE) has been adopted by WADA
and is utilized in speciﬁc circumstances10. Two key aspects
of this international standard are: 1) ′′The Athlete would
experience a signiﬁcant impairment to health if the Prohib-
ited Substance or Prohibited Method were to be withheld in
the course of treating an acute or chronic medical condition′′
(4.1.a); 2) ′′There is no reasonable therapeutic alternative
to the use of the otherwise Prohibited Substance or Prohib-
ited Method′′ (4.1.c)10. A further complicating factor in the
medical treatment of the athlete is that speciﬁc substances
may be prohibited at all times or in certain instances only
when the athlete is in competition11.
Treatment of attention-deﬁcit/hyperactivity disorder
(ADHD) within the athletic population is a unique chal-
lenge. The most recent practice parameter from the
American Academy of Child and Adolescent Psychiatry
for the treatment of ADHD summarized recommendations
from the American Academy of Pediatrics, the Texas Chil-
dren’s Medication Algorithm Project, and an international
consensus statement; all three listed stimulants as the
ﬁrst-line treatment for ADHD12—15. However, WADA bans
stimulants in competition and it has been suggested that
methylphenidate could be taken until twenty-four hours
pre-competition in order to allow drug clearance11,16. Were
the athlete and his physician to ﬁnd stimulants necessary
in competition to control ADHD, obtaining a TUE could
pose difﬁculties. Speciﬁcally, based on the international
standard, a TUE is not permitted unless alternative, non-
prohibited medications have ﬁrst been tried and found to
be ineffective10. The only non-stimulant approved by the
FDA for the treatment of ADHD is atomoxetine, a selective
norepinephrine reuptake inhibitor (SNRI)12. While similar
efﬁcacy in the treatment of ADHD has been reported with
the non-stimulant atomoxetine compared to the stimulant
methylphenidate, a meta-analysis revealed a greater effect
size for stimulants compared to atomoxetine17,18. Thus it
is implied that the athlete must ﬁrst have undergone a
potentially unsuccessful therapeutic trial with atomoxetine,
which may have arguably inferior results, prior to initiating
stimulants14.ADHD is one of the most prevalent neuropsychiatric disor-
ders of childhood and adolescence. Worldwide ADHD pooled
prevalence has been reported to be 5.3%, ranging from Mid-
dle East’s 2.4%, Europe’s 4.6%, North America’s 6.3%, to
i
w
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outh America’s 11.8%, with prevalence in boys 10.1%, girls
.1%, children 6.5%, and adolescents 2.7%19. Nonetheless,
here are no prevalence studies of ADHD in sports. It is
ifﬁcult to address some of the controversial issues asso-
iated with stimulants in sports if the number of athletes
ho require such is not known.
The aims of this study are to address preliminary ﬁndings
egarding ADHD in a boys’ gymnastic team, implications for
urther studies with proposed research survey questionnaire
o measure prevalence of ADHD with behavioral effects of
ymnastics, and ethical considerations.
ethod
arents of a boys’ gymnastic team were informally inter-
iewed by the senior author during gymnastic practices, at
ymnastic meets, and at social settings. Boys competing for
hat gymnastic team were similarly observed by the senior
uthor. Further data was obtained from informal inter-
iews of parents at local, regional, and invitational meets.
ata accumulation occurred during a 30-month time period.
hese interviews and observations permitted determination
f the primary outcome measure, prevalence of ADHD in
boys’ gymnastic team. The secondary outcome measure,
ehavioral effects of gymnastics on ADHD, was suggested
y these interviews. The third outcome measure was par-
nts’ knowledge of the WADC prohibition of in-competition
timulant use and the need for TUE.
To better address these preliminary ﬁndings, a brief sur-
ey was developed to estimate the actual prevalence of
iagnosis and treatment of ADHD in the gymnastic popula-
ion in future studies.
A review of the available literature concerning thera-
eutic stimulant use in sports and treatment effects was
nitiated to complement the preliminary ﬁndings from the
arents’ informal interviews and discussions with peers.
ubMed, PsycINFO, Lexis-Nexis, and Google databases were
tilized for the literature review. Search terms included but
ere not limited to: attention-deﬁcit/hyperactivity disor-
er (ADHD), prevalence, treatment, stimulant, psychotropic
edication, behavioral effects, gymnastics, boys, survey,
orld Anti-Doping Agency (WADA), World Anti-Doping Code
WADC), doping, therapeutic use exemption (TUE), ethics,
ports, and Raducan.
esults
uring a 30-month time period, the senior author infor-
ally interviewed all fourteen parents of a boys’ gymnastic
eam as well as observed the boys competing for that gym-
astic team in multiple settings. These informal interviews
nd observations permitted determination of the primary
utcome measure, prevalence of ADHD in a boys’ gym-
astic team. Speciﬁcally, the parents reported that 5 of
(71.4%) boys in a gymnastic team were either diag-
osed with ADHD in the past or had been treated with
sychotropic medications, stimulant or non-stimulant, for
nattentive/hyperactive/impulsive behaviors.
Five additional parents of ﬁve gymnasts from other teams
ithin the region made similar reports regarding their sons
aving ADHD or having used psychotropic medications to
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reat core ADHD symptoms. The comments from the ﬁf-
een parents (ten from the team and these ﬁve additional
arents) whose sons had been diagnosed with ADHD or had
een treated with psychotropic medications for ADHD core
ymptoms were utilized to address the secondary outcome
easure, behavioral effects of gymnastics on ADHD. Speciﬁ-
ally, all ﬁfteen parents described gymnastics as an effective
orm of ′′behavioral therapy′′ in controlling or improving
DHD symptoms and that this effect carried into other envi-
onments such as the home and classroom settings. Reported
eneﬁts included improvements in behavior as well as aca-
emic performance.
Responses from all nineteen parents were utilized for the
hird outcome measure, knowledge of the WADC. Only one
arent of nineteen parents was cognizant of the WADC pro-
ibition of in-competition stimulant use and the need for
UE.
Based on these preliminary outcome measure results, the
uthors developed and now present the new ′′Gymnastics
nd ADHD: Stimulant Medication, Therapy, and Behavior
urvey′′ to estimate actual ADHD prevalence/treatment in
he gymnastic population, potential behavioral effects of
ymnastics on ADHD, and knowledge of the WADC in future
tudies.
iscussion
hrough regular practice and competitions, gymnastic fam-
lies readily become comrades over the course of one
eason and increasingly so throughout subsequent seasons.
t the initial compulsory levels, competitions are within the
tate; but as the gymnast advances, competitions become
egional, involving multiple states, and eventually national.
hile parents ﬁrst interact with their child’s own team’s
arents, with advancement of the gymnast, parents increas-
ngly interact with other parents of gymnasts from other
eams within the state, the region, and ﬁnally the nation. As
result of this camaraderie, it is not surprising that parents
penly described in detail their child’s behaviors in home
nd school settings and how gymnastics has played a role in
he gymnast’s behavioral and academic improvement. Fur-
her, in discussing these issues, parents also volunteered
he existence of a prior diagnosis of ADHD and/or a his-
ory of medication treatment, stimulant or non-stimulant,
or core symptoms of ADHD (inattention/hyperactivity/
mpulsivity).
At one Invitational, the senior author complimented a
other on her son’s performance and sportsmanship. Her
erception of the behavioral effects of gymnastics on ADHD
s concisely summarized in her response: ′′You should have
een him one year ago; you cannot imagine how signiﬁcant
ymnastics has been for him. My son has ADHD and takes
edication; but with gymnastics, his behavior is so much
etter at home and in the school, his grades are better and
e needs less medication. I know it’s the ﬁrst time we talked,
ut I am so very happy that I could share.′′ This interaction
xempliﬁes the above-described relationship among parents
f gymnasts.
The preliminary ﬁndings noted in this paper are quite
nexpected. Were they to be generalized, these ﬁndings
ould suggest a greater than ﬁve-fold prevalence of ADHD
e
a
t
aK.R. Kaufman et al
n the boy gymnastic population compared to the national
DHD prevalence for boys19. That such a cluster was found
s even more unusual considering the literature suggests a
ecreased interest in sports as well as athleticism in chil-
ren and adolescents with ADHD16,20. In one study only 2/3 of
DHD children were motivated to participate in sports; other
tudies and reviews referred to children with ADHD having
ecreased coordination, impaired motor ability, clumsiness,
nd poor balance16,20—23. Further, >50% of children with ADHD
ave also been diagnosed with developmental coordination
isorder (DCD)24,25. Finally, one survey suggested that gym-
astics is one of the least suitable sports for untreated
DHD youth athletes26. It is important to determine whether
hese preliminary prevalence ﬁndings are secondary to small
ample size only or are in fact accurate; in addition, it is
mportant to address why ADHD boy gymnasts might gravi-
ate toward gymnastics. Clearly the results presented point
o the potential signiﬁcance of a much larger study to bet-
er estimate the actual prevalence in gymnastics. The brief
′Gymnastics and ADHD: Stimulant Medication, Therapy, and
ehavior Survey′′ is included in this paper; it will be ini-
ially utilized regionally and if the results are positive will
e expanded nationally. Also, in light of different preva-
ence of ADHD internationally, it might be beneﬁcial to
ave this study done as a multi-national study under the
uspices of the Fédération Internationale de Gymnastique
FIG).
Key to the success of an athlete is his ability to pay atten-
ion to coaching instruction and thereafter to incorporate
hat he has learned into his performance. Though limited
tudies have been done comparing athletes with ADHD with
nd without medication, it has been inferred that ′′With
reatment they may be able to focus better on a speciﬁc
ask, and may be more aware of position and time26.′′
To better understand the attention required in gymnas-
ics, it is important to appreciate the total time spent
nnually in gymnastic practice compared to the total time
n actual competition. Optional (Levels 8, 9, 10) and elite
ymnasts practice year round between 15-20 hours per week
47,250minutes); yet these same gymnasts may only com-
ete in 8 competitions in a given year (120minutes). Thus
nly 0.25% of all time spent in gymnastic practice equates
o the total time in competition.
It is critical to pay attention to everything that is happen-
ng in practice sessions as well as during the competitions
hemselves. It is more than simply listening to the coach
nd remembering the routine for a speciﬁc apparatus. To be
n excellent gymnast requires the individual to pay atten-
ion to his body, to have body awareness —–be it a question
f position or balance (static and dynamic) or strength or
ain with creation of an inner awareness27—31. Although the
ymnast is invested in the outcome of his own routine, he
an learn from watching the routines of other gymnasts
egarding both techniques and even pitfalls for a given com-
etition —–for example, to obtain a stick bonus on a landing
aving an uneven mat, the gymnast learns not only from
is warm-ups but also from observing the landings of his
ellow gymnasts. In essence the elite gymnast must have
xcellent skills of observation (self and others), imagery,
nd self-talk while being able to listen to coach’s feedback
o maximize self-assessment, improve technical execution,
nd improve visual perceptions32. Also, it is important to
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pay attention to the judges —–their signals and facial expres-
sions can yield valuable information in competition. Further,
it is very important that the gymnast not be impulsive in
his behaviors or in his routines —–once his arm is raised to
salute the judges his scoring begins and every move he makes
counts until he ends his routine by saluting the judges again.
Even if a gymnast were to accidentally break his routine
and need to rapidly complete a different set of skills to ﬁn-
ish his apparatus, what might seem impulsive, is in reality
a gymnast’s complicated correction performed with great
attention to detail. One gymnast was asked to describe how
he would correct his position mid-routine were he to ﬁnd
himself after a drop cast too close to the end of the parallel
bars; he instantly responded by describing a complex series
of consecutive skills that would bring him back to the middle
of the bars: ′′«back up-rise; L; press handstand; pirouette;
shoulder stand; and, ﬁnally, roll back up-rise straddle cut
to an L.′′ Clearly being a gymnast is more than physical,
there is a strong cognitive component focused on attention
and impulse control. Since a boy gymnast with ADHD can
win state and regional championships, perhaps it is time for
future studies to consider whether successful performance
can be because of, rather than in spite of, ADHD.
Several key questions must now be considered. 1) Is gym-
nastics a behavior treatment for ADHD wherein there is the
development of greater attention and decreased impulsiv-
ity with carryover into other environments? 2) Can sport
itself have a positive effect independent of the associated
physical exercise? 3) Do stimulants improve performance in
athletes with ADHD?
First, several reports suggest that exercise can increase
calmness, decrease motor impersistence, improve behavior,
and function as a dopaminergic adjuvant33—36.
Second, competitive gymnastics functions as a token
economy consisting of frequent praise with competition rib-
bons for all participants at the lower levels and half of the
gymnasts in optional levels at invitational meets. Improved
sportsmanlike behaviors have been reported with tokens and
praise in ADHD children37.
Third, the performance-enhancing effects of stimulants
in athlete with ADHDhave been debated as there are
conﬂicting ﬁndings, some suggesting that performance is
actually impaired16,22,26,38. In addition to potentially signif-
icant individual variability, the response to stimulants in
an athlete with ADHD may be dependent on gender, age,
and speciﬁc sport. There is insufﬁcient research to clearly
answer these three questions which supports the need for
further investigations focused speciﬁcally on the athlete
with ADHD.
To handicap an athlete with ADHD by preventing the
requisite medication to maximize attention and dimin-
ish impulsivity should be construed as unethical; however,
WADA/WADC prohibits stimulants11,26,39. Should every newly
diagnosed athlete with ADHD initially be treated with a
non-stimulant medication? Presently only ∼50% of all chil-
dren with ADHD are receiving treatment consistent with
the guidelines from the American Academy of Child and
Adolescent Psychiatry40. What if the child were diagnosed
with ADHD and initiated on successful stimulant treatment
prior to initiating athletics, should the now athlete with
ADHD be forced to change to a potentially less effective
non-stimulant treatment with reportedly increased adverse
d
i
t
rreliminary ﬁndings 93
ffects17,18? In essence, is it appropriate that relevant
ational or international Therapeutic Use Exemption Com-
ittees (TUECs) function as medical arbiters instead of the
reating physician?
Limitations to this paper include the small sample size,
bservational evidence, only parent reports, and no stan-
ardized instrument to verify ADHD diagnosis. Further there
re limitations to the proposed survey, which though having
ace validity has not been validated. Speciﬁcally, a survey
an be all inclusive with resultant limited responses due
o the burden of the survey itself, or the survey can have
ewer but directed questions to maximize responses. In this
tudy, the authors chose to pursue a more focused survey.
his clearly leads to speciﬁc limitations:
No data is obtained concerning the number of gymnasts
not formally diagnosed with ADHD but nonetheless being
treated with non-stimulant medications effective for this
diagnosis.
No data is obtained regarding siblings without formal
diagnosis of ADHD but with symptoms of hyperactiv-
ity/inattention/impulsivity.
No data is obtained as to whether gymnastics was selected
as a treatment for ADHD by the gymnast’s parents.
Though the survey does inquire as to other psychi-
atric diagnoses, the survey does not target common
co-morbidities.
The key strengths in the survey thus become its brevity
nd focus on prevalence.
When one considers the future for athletes with ADHD
nd the potential use of stimulants in-competition, it is
mportant to better appreciate the prevalence of ADHD in
peciﬁc athletic populations and whether stimulants have
erformance enhancing effects for the athlete with ADHD
n speciﬁc sports. The authors personally expect that the
lanned study will reveal an increased prevalence of ADHD
n the gymnastic population compared to the national preva-
ence leading to increased studies and whether stimulants
ave performance-enhancing effects for the athlete with
DHD in speciﬁc sports. The authors believe that only
hen will the issue of in-competition stimulant use by the
thlete with ADHDbe appropriately solved. Both the ath-
ete with ADHDand the professionals involved in his care
medical clinicians, trainers and coaches) have responsi-
ilities to ensure that substances on the WADC Prohibited
ist are not utilized and that, as necessary, the appro-
riate TUE is obtained. Further research and education
re required in this complex ﬁeld of anti-doping in sports
edicine.
onclusion
n the context of a small sample population (N = 7), ADHD
revalence is reported in a surprisingly large proportion
71.4%) of gymnasts in a boys’ gymnastic team. Detailed
urvey of a larger number of gymnasts of both gen-
ers is required to verify the high prevalence of ADHD
n this population and behavioral effects of gymnas-
ics reported by parents in this one team. A proposed
esearch survey questionnaire to measure both prevalence
9 K.R. Kaufman et al
o
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table 1 table 1).
Table 1 Gymnastics and ADHD: Stimulant Medication,
Therapy, and Behavior Survey.
Section I —– Demographics
Gymnast’s age:
Gymnast’s gender:
Gymnast’s level:
Years participated in gymnastics:
Survey completed by:
Relationship to athlete:
Section II —– Survey
1. Has the gymnast ever been diagnosed as having ADHD
or ADD?
a. Yes.
b. No.
2. Who diagnosed the gymnast?
a. Pediatrician.
b. Psychiatrist.
c. Child Psychiatrist.
d. Therapist.
e. Other, please specify.
3. Is the gymnast CURRENTLY being treated with
stimulant medication for either ADHD/ADD or
symptoms of hyperactivity/inattention/impulsivity?
a. Yes, please specify medication.
b. No.
4. Is the gymnast CURRENTLY being treated with therapy
for either ADHD/ADD or symptoms of
hyperactivity/inattention/impulsivity?
a. Yes, please specify therapy type if known.
b. No.
5. Was the gymnast EVER treated with stimulant
medication for ADHD/ADD or symptoms of
hyperactivity/inattention/impulsivity in the PAST?
a. Yes, please specify medication.
b. No.
6. Was the gymnast EVER treated with therapy for
ADHD/ADD or symptoms of
hyperactivity/inattention/impulsivity in the PAST?
a. Yes, please specify type.
b. No.
7. Do you feel the gymnast’s ADHD/ADD symptoms or
symptoms of hyperactivity/inattention/impulsivity
have improved or worsened after starting
gymnastics?
a. Improved, please specify.
b. Worsened, please specify.
c. No change observed.
d. Not applicable.
8. Has the change in symptoms of ADHD/ADD or
hyperactivity/inattention/impulsivity carried over
into other environments such as home or school?
a. Yes, please specify.
b. No, please specify.
c. Unsure.
d. Not applicable.
9. Do you feel the gymnast’s performance during
competitions is affected by medication treatment?
a. Yes, performance is IMPROVED with medication.
b. Yes, performance is WORSENED with medication.
c. No, no obvious difference in performance with or
without medication
10. Does the gymnast have any current/prior psychiatric
diagnoses aside from ADHD or ADD?
a. Yes, please specify.
b. No.
11. Have any members of the gymnast’s biological family
been diagnosed with ADHD or ADD?
a. Yes, please specify who.
Are they also involved in gymnastics?
b. No
12. Has the gymnast ever been identiﬁed as misusing
alcohol, over-the-counter or illicit drugs?
a. Yes, please specify what substances.
b. No
13. Are you currently aware of the World Anti-Doping
Code and/or USA Anti-Doping Code policies
regarding stimulant medications often used to treat
ADHD/ADD?
a. Yes.
b. No.
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